 Avalon GloboCare Corp NASDAQ:ALBT has announced that the US Patent and Trademark Office USPTO has issued it with US Patent No. 11,555,060, titled QTY Fc Fusion Water Soluble Receptor Proteins, which was jointly filed with Dr Shuguang Zhang of the Massachusetts Institute of Technology MIT. 